UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000040391
Receipt number R000045899
Scientific Title Changes in baroreflex before and after Transcatheter Aortic Valve Implantation. Does autonomic function affect baroreflex recovery?
Date of disclosure of the study information 2020/06/01
Last modified on 2023/04/24 16:47:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Changes in baroreflex before and after Transcatheter Aortic Valve Implantation.

Does autonomic function affect baroreflex recovery?

Acronym

Changes in baroreflex before and after Transcatheter Aortic Valve Implantation.

Does autonomic function affect baroreflex recovery?

Scientific Title

Changes in baroreflex before and after Transcatheter Aortic Valve Implantation.

Does autonomic function affect baroreflex recovery?

Scientific Title:Acronym

Changes in baroreflex before and after Transcatheter Aortic Valve Implantation.

Does autonomic function affect baroreflex recovery?

Region

Japan


Condition

Condition

Severe aortic stenosis

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate whether baroreflex changes before and after TAVI are affected by preoperative autonomic function.

Basic objectives2

Others

Basic objectives -Others

A multivariate analysis will be performed on the background factors that were found to be related, in order to search for factors that influence changes in postoperative BRS.

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Baroreflex sensitivity
(pre operation,post operation,after 1 year)

Key secondary outcomes

All deaths
Cardiovascular death
All readmissions
Cardiovascular readmission
Heart rate variability analysis
Frailty scale
Barthel Index
Grip strength, knee extension strength, 4m walking speed
Mini-Cog


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Evaluation of autonomic function by heart rate variability analysis
Baroreceptor reflex sensitivity measurement by tilt table test

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit

99 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients diagnosed with aortic stenosis and undergoing transcatheter aortic valve implantation at our hospital
over 65 years old
Men and women do not matter
Mini Cog 3 points or more

Key exclusion criteria

Patients with a pacemaker inserted
Patients with atrial fibrillation

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Yamauti
Middle name
Last name Katsuya

Organization

Hamamatsu University School of Medicine,University Hospital

Division name

Department of Rehabilitation

Zip code

431-3125

Address

1-20-1 Handayama, Higashi-ku, Hamamatsu City, Shizuoka Prefecture

TEL

053-435-2111

Email

yamakatu@hama-med.ac.jp


Public contact

Name of contact person

1st name Masahiro
Middle name
Last name Toda

Organization

Hamamatsu University School of Medicine,University Hospital

Division name

Department of Rehabilitation

Zip code

431-3125

Address

1-20-1 Handayama, Higashi-ku, Hamamatsu City, Shizuoka Prefecture

TEL

053-435-2111

Homepage URL


Email

07485098@hama-med.ac.jp


Sponsor or person

Institute

Hamamatsu University School of Medicine,University Hospital

Institute

Department

Personal name



Funding Source

Organization

No

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Hamamatsu University School of Medicine,University Hospital

Address

1-20-1 Handayama, Higashi-ku, Hamamatsu City, Shizuoka Prefecture

Tel

053-435-211

Email

yamakatu@hama-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

浜松医科大学医学部附属病院


Other administrative information

Date of disclosure of the study information

2020 Year 06 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2020 Year 03 Month 03 Day

Date of IRB

2021 Year 10 Month 20 Day

Anticipated trial start date

2020 Year 11 Month 15 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

In March 2021, a device failure was discovered. Equipment failures make it difficult to use the data collected so far for statistical analysis. I applied to the Institutional Review Board for the use of the new equipment. Registration for the study was resumed in November with the approval of the Institutional Review Board.

lthough data were collected continuously, there were more subjects with atrial fibrillation than expected among the study subjects.
Since it was difficult to analyze those with atrial fibrillation in the HRV analysis, we determined that it would be difficult to continue the current study and decided to discontinue it.


Management information

Registered date

2020 Year 05 Month 13 Day

Last modified on

2023 Year 04 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045899


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name